Pentoxifylline attenuates ischemia/reperfusion injury to the small intestine in the rat

Pediatric Surgery International

Volumn 11, Issue 5-6, 1996, Pages 329-333

  Udassin, R ^a   Vromen, A ^a   Seror, D ^a   Haskel, Y ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Animal model; Intestine; Ischemia; Pentoxifylline

Indexed keywords

METHYLXANTHINE DERIVATIVE; MYELOPEROXIDASE; PENTOXIFYLLINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CLAMP; ARTICLE; CONTROLLED STUDY; ENZYME ASSAY; HEMORRHAGIC SHOCK; HISTOLOGY; INTESTINE BLOOD FLOW; INTESTINE ISCHEMIA; INTESTINE MUCOSA; INTESTINE PERFUSION; LEUKOCYTE ADHERENCE; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SEPSIS; SUPERIOR MESENTERIC ARTERY; VASCULAR ENDOTHELIUM;

EID: 0029992243     PISSN: 01790358     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00497805     Document Type: Article

References (49)

1. Barroso AJ, Schmid SG (1990) Pentoxifylline pretreatment decreases the pool of circulating activated neutrophils, in-vivo adhesion to endothelium, and improves survival from hemorrhagic shock. Biorheology 27: 401-418
2. Berens KL, Langsten JD, Wasan KM, Luke DR (1991) Influence of pentoxifylline and related analogues in endotoxemic renal failure. Circ Shock 34: 344-348
3. Bessler H, Gilgal R, Djaldetti M, Zahavi I (1986) Effect of pentoxifylline on the phagocytic activity, cAMP levels, and superoxide anion production by monocytes and polymorphonuclear cells. J Leukoc Biol 40: 747-754
4. Blume J, Ruhlmann KU, de la Haye R, Rettig K (1992) Treatment of chronic cerebrovascular disease in elderly patients with pentoxifylline. J Med 23: 417-432
5. Boogaerts MA, Malbrain S, Meeus P, van Hove L, Verhoef GE (1990) In vitro modulation of normal and diseased human neutrophil function by pentoxifylline. Blut 61: 60-65
6. Bowton DL, Stump DA, Prough DS, Toole JF, Lefkowitz DS, Coker L (1989) Pentoxifylline increases cerebral blood flow in patients with cerebrovascular disease. Stroke 20: 1662-1666
7. Caplan MS, MacKendrick W (1993) Necrotizing enterocolitis: a review of pathogenetic mechanisms and implications for prevention. Pediatr Pathol 13: 357-369
8. Ciuffetti G, Mercuri M, Ott C, Lombardini R, Paltriccia R, Lupattelli G, Santambrogio L, Mannarino E (1991) Use of pentoxifylline as an inhibitor of free radical generation in peripheral vascular disease. Results of a double-blind placebo-controlled study. Eur J Clin Pharmacol 41: 511-515
9. Ciuffetti G, Paltriccia R, Lombardini R, Lupattelli G, Pasqualini L, Mannarino E (1994) Treating peripheral arterial occlusive disease: pentoxifylline vs exercise. Int Angiol 13: 33-39
10. Dauber IM, Lesnefsky EJ, Ashmore RC, Martel DM, Sheridan FM, Weit JV, Horwitz LD (1992) Coronary vascular injury due to ischemia-reperfusion is reduced by pentoxifylline. J Pharmacol Exp Ther 260: 1250-1256
11. Dettelbach HR, Aviado DM (1985) Clinical pharmacology of pentoxifylline with special reference to its hemorrheologic effect for the treatment of intermittent claudication. J Clin Pharmacol 25: 8-26
12. Ernst E, Kollar L, Resch KL (1992) Does pentoxifylline prolong the walking distance in exercised claudicants? A placebo-controlled double-blind trial. Angiology 43: 121-125
13. Flynn WJ, Cryer HG, Garrison RN (1991) Pentoxifylline but not saralasin restores hepatic blood flow after resuscitation from hemorrhagic shock. J Surg Res 50: 616-621
14. Flynn WJ, Cryer HG, Garrison RN (1991) Pentoxifylline restores intestinal microvascular blood flow during resuscitated hemorrhagic shock. Surgery 110: 350-356
15. Granger DN, Kvietys PR, Perry MA (1993) Leukocyte-endothelial cell adhesion induced by ischemia and reperfusion. Can J Physiol Pharmacol 71: 67-75
16. Grisham MB, Benoit JN, Granger DN (1990) Assessment of leukocyte involvement during ischemia and reperfusion of intestine. Methods Enzymol 186: 729-742
17. Hadjiminas DJ, McMasters KM, Robertson SE, Cheadle WG (1994) Enhanced survival from cecal ligation and puncture with pentoxifylline is associated with altered neutrophil trafficking and reduced interleukin-1 beta expression but not inhibition of tumor necrosis factor synthesis. Surgery 116: 348-355
18. Hakim TS, Petrella J (1988) Attenuation of pulmonary and systemic vasoconstriction with pentoxifylline and aminophylline. Can J Physiol Pharmacol 66: 396-401
19. Hewett JA, Jean PA, Kunkel SL, Roth RA (1993) Relationship between tumor necrosis factor-alpha and neutrophils in endotoxin-induced liver injury. Am J Physiol 265: G1011-G1015
20. Ishizaka A, Hatherill JR, Harada H, Yonemaru M, Hoffmann H, Zheng H, O'Hanley PT, Raffin TA (1989) Prevention of interleukin 2-induced acute lune injury in guinea pigs by pentoxifylline. J Appl Physiol 67: 2432-2437
21. Jewett A, Bonavida B (1994) Pentoxifylline suppresses interleukin-2-mediated activation of immature human natural killer cells by inhibiting endogenous tumor necrosis factor-alpha secretion. J Clin Immunol 14: 31-38
22. Korthuis RJ, Granger DN (1993) Reactive oxygen metabolites, neutrophils, and the pathogenesis of ischemic-tissue/reperfusion. Clin Cardiol 16: 119-126
23. Kremsner PG, Neifer S, Chaves MF, Rudolph R, Bienzle U (1992) Interferon-gamma induced lethality in the late phase of Plasmodium vinckei malaria despite effective parasite clearance by chloroquine. Eur J Immunol 22: 2873-2878
24. Langer JC, Sohal SS, Mumford DA (1993) Mucosal permeability in the immature rat intestine: effects of ischemia-reperfusion, cold stress, hypoxia, and drugs. J Pediatr Surg 28: 1380-1383
25. Mavrelis PG, Doumanian H (1987) Pentoxifylline for mesenteric ischemia. Am J Gastroenterol 82: 175
26. Megison SM, Horton JW, Chao H, Walker PB (1990) A new model for intestinal ischemia in the rat. J Surg Res 49: 168-173
27. Michal M, Giessinger N, Schroer R (1989) Reduced thrombus formation in vivo after administration of pentoxifylline (Trental). Thromb Res 56: 359-368
28. Mitsudo S, Brandt LJ (1992) Pathology of intestinal ischemia. Surg Clin North Am 72: 43-63
29. Mollitt DL, Poulos ND (1991) The role of pentoxifylline in endotoxin-induced alterations of red cell deformability and whole blood viscosity in the neonate. J Pediatr Surg 26: 572-574
30. Musemeche CA, Pizzini RP, Andrassy RJ (1993) Intestinal ischemia in the newborn: the role of intestinal maturation. J Surg Res 55: 595-598
31. Prada J, Prager C, Neifer S, Bienzle U, Kremsner PG (1993) Production of interleukin-6 by human and murine mononuclear leukocytes stimulated with Plasmodium antigens and tumor necrosis factor secretion is reduced. Infect Immun 61: 2737-2740
32. Raj JU, Kaapa P, Anderson J (1992) Age-related differences in vascular effects of pentoxifylline in isolated perfused ferret lungs. Dev Pharmacol Ther 18: 1-8
33. Refsum SE, Norwood W, Rowlands BJ, Boston VE (1993) Pentoxifylline improves resting membrane potential in sepsis. J Pediatr Surg 28: 1144-1146
34. Reignier J, Mazmanian M, Detruit H, Chapelier A, Weiss M, Libert JM, Hervé P (1994) Reduction of ischemia-reperfusion injury by pentoxifylline in the isolated rat lung. Paris-Sud University Lung Transplantation Group. Am J Respir Crit Care Med 150: 342-347
35. Schade UF (1990) Pentoxifylline increases survival in murine endotoxin shock and decreases formation of tumor necrosis factor. Circ Shock 31: 171-181
36. Schroer RH (1985) Antithrombotic potential of pentoxifylline. A hemorrheologically active drug. Angiology 36: 387-398
37. Sigurdsson GH, Youssef H (1993) Effects of pentoxifylline on hemodynamics, gas exchange and multiple organ platelet sequestration in experimental endotoxic shock. Acta Anaesthesiol Scand 37: 396-403
38. Suzuki K, Ota H, Sasagawa S, Sakatani T, Fujikura T (1983) Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem 132: 345-352
39. Tighe D, Moss R, Hynd J, Boghossian S, Saady N, Heath MF, Bennett ED (1990) Pretreatment with pentoxifylline improves the hemodynamic and histologie changes and decreases neutrophil adhesiveness in a pig fecal peritonitis model. Crit Care Med 18: 184-189
40. Toung TJ, Kirsch JR, Maruki Y, Traystman RJ (1994) Effects of pentoxifylline on cerebral blood flow, metabolism, and evoked response after total cerebral ischemia in dogs. Crit Care Med 22: 273-281
41. Udassin R, Ariel I, Haskel Y, Kitrossky N, Chevion M (1991) Salicylate as an in vivo free radical trap: studies on ischemic insult to the rat intestine. Free Radic Biol Med 10: 1-6
42. Udassin R, Vromen A, Haskel Y (1994) The time sequence of injury and recovery following transient reversible intestinal ischemia. J Surg Res 56: 221-225
43. van Leenen D, van der Poll T, Levi M, ten Cate H, van Deventer S, Hack CE, Aarden LA, ten Cate J (1993) Pentoxifylline attenuates neutrophil activation in experimental endotoxemia in chimpanzees. J Immunol 151: 2318-2325
44. Wang P, Ba ZF, Zhou M, Tait SM, Chaudry IH (1993) Pentoxifylline restores cardiac output and tissue perfusion after traumahemorrhage and decreases susceptibility to sepsis. Surgery 114: 352-358
45. Waxman K, Eloi L, Dinh L, Scannell G, Tominaga GT (1993) Pentoxifylline alone versus pentoxifylline combined with superoxide dismutase prolongs survival in a rat hemorrhagic shock model. Resuscitation 26: 237-242
46. Yonemaru M, Hatherill JR, Hoffmann H, Zheng H, Ishii K, Raffin TA (1991) Pentoxifylline does not attenuate acute lung injury in the absence of granulocytes. J Appl Physiol 71: 342-351
47. Zabel P, Schade FU, Schlaak M (1993) Inhibition of endogenous TNF formation by pentoxifylline. Immunobiology 187: 447-463
48. Zheng H, Crowley JJ, Chan JC, Raffin TA (1991) Attenuation of LPS-induced neutrophil thromboxane b2 release and chemiluminescence. J Cell Physiol 146: 264-269
49. Zimmerman BJ, Granger DN (1992) Reperfusion injury. Surg Clin North Am 72: 65-83